The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Reviewed by Dietitian Emily Lachtrupp, M.S., RD Ever since berberine made headlines last year for being touted as “nature’s ...

Discover the latest research on Ozempic and other GLP-1 medications, including potential uses in treating Alzheimer's and opioid and alcohol use disorders.

In Quebec, anti-obesity medications are on the list of exclusions of the Régie de l’assurance maladie du Québec (RAMQ). Quebec is the only Canadian province that does not evaluate obesity medications ...

"If a patient has a BMI of 40 (meaning they're roughly 80 to 100 pounds overweight for their height) or a BMI of 35 with ...

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

The diabetes drug semaglutide, also known as Ozempic, has a positive effect on patients with chronic kidney disease and ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Body image is a topic that is regularly talked about in Hollywood, as countless celebrities like Serena Williams, Demi Lovato ...